Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
13801
13802
13803
13804
13805
13806
13807
13808
13809
13810
13811
13812
13813
13814
13815
13816
13817
13818
13819
13820
13821
13822
13823
13824
13825
13826
13827
13828
13829
13830
13831
13832
13833
13834
13835
13836
13837
13838
13839
13840
13841
13842
13843
13844
13845
13846
13847
13848
13849
13850
13851
13852
13853
13854
13855
13856
13857
13858
13859
13860
13861
13862
13863
13864
13865
13866
13867
13868
13869
13870
13871
13872
13873
13874
13875
13876
13877
13878
13879
13880
13881
13882
13883
13884
13885
13886
13887
13888
13889
13890
13891
13892
13893
13894
13895
13896
13897
13898
13899
13900
13901
13902
13903
13904
13905
13906
13907
13908
13909
13910
13911
13912
13913
13914
13915
13916
13917
13918
13919
13920
13921
13922
13923
13924
13925
13926
13927
13928
13929
13930
13931
13932
13933
13934
13935
13936
13937
13938
13939
13940
13941
13942
13943
13944
13945
13946
13947
13948
13949
13950
13951
13952
13953
13954
13955
13956
13957
13958
13959
13960
13961
13962
13963
13964
13965
13966
13967
13968
13969
13970
13971
13972
13973
13974
13975
13976
13977
13978
13979
13980
13981
13982
13983
13984
13985
13986
13987
13988
13989
13990
13991
13992
13993
13994
13995
13996
13997
13998
13999
14000
| UnnamedSample_HQ_transcript/62405|m.16524 | UnnamedSample_HQ_transcript/62405 | Identity 0.911 too low. | f1a9ab2feb67b566f7546745a938cccc | 377 | Pfam | PF03250 | Tropomodulin | 13 | 152 | 5.3E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/58079|m.15668 | UnnamedSample_HQ_transcript/58079 | Identity 0.920 too low. | f1a9ab2feb67b566f7546745a938cccc | 377 | Pfam | PF03250 | Tropomodulin | 13 | 152 | 5.3E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/44166|m.12753 | UnnamedSample_HQ_transcript/44166 | Coverage 0.044 too low. | da042476a5877ee4e014ee29bceeffb4 | 471 | Pfam | PF00732 | GMC oxidoreductase | 4 | 215 | 3.6E-57 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/44166|m.12753 | UnnamedSample_HQ_transcript/44166 | Coverage 0.044 too low. | da042476a5877ee4e014ee29bceeffb4 | 471 | Pfam | PF05199 | GMC oxidoreductase | 309 | 449 | 4.8E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/37934|m.11382 | UnnamedSample_HQ_transcript/37934 | Identity 0.844 too low. | 5320da36747fa391136b55e05e207c89 | 692 | Pfam | PF06920 | Dock homology region 2 | 151 | 675 | 1.3E-209 | T | 22-09-2020 | IPR010703 | Dedicator of cytokinesis, C-terminal |
| UnnamedSample_HQ_transcript/118174|m.24691 | UnnamedSample_HQ_transcript/118174 | Coverage 0.814 too low. | d535660f458ab94fcb4c54410f801b55 | 218 | Pfam | PF00168 | C2 domain | 119 | 203 | 8.0E-5 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/118174|m.24691 | UnnamedSample_HQ_transcript/118174 | Coverage 0.814 too low. | d535660f458ab94fcb4c54410f801b55 | 218 | Pfam | PF00168 | C2 domain | 2 | 67 | 1.4E-7 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/18704|m.6497 | UnnamedSample_HQ_transcript/18704 | Coverage 0.984 too low. | 80c9708f1de81082646bce44ac7c4194 | 1026 | Pfam | PF02171 | Piwi domain | 681 | 986 | 2.0E-85 | T | 22-09-2020 | IPR003165 | Piwi domain |
| UnnamedSample_HQ_transcript/18704|m.6497 | UnnamedSample_HQ_transcript/18704 | Coverage 0.984 too low. | 80c9708f1de81082646bce44ac7c4194 | 1026 | Pfam | PF02170 | PAZ domain | 435 | 535 | 1.2E-9 | T | 22-09-2020 | IPR003100 | PAZ domain |
| UnnamedSample_HQ_transcript/18704|m.6497 | UnnamedSample_HQ_transcript/18704 | Coverage 0.984 too low. | 80c9708f1de81082646bce44ac7c4194 | 1026 | Pfam | PF08699 | Argonaute linker 1 domain | 349 | 403 | 3.7E-9 | T | 22-09-2020 | IPR014811 | Argonaute, linker 1 domain |
| UnnamedSample_HQ_transcript/18704|m.6497 | UnnamedSample_HQ_transcript/18704 | Coverage 0.984 too low. | 80c9708f1de81082646bce44ac7c4194 | 1026 | Pfam | PF16486 | N-terminal domain of argonaute | 210 | 322 | 7.6E-10 | T | 22-09-2020 | IPR032474 | Protein argonaute, N-terminal |
| UnnamedSample_HQ_transcript/56887|m.15423 | UnnamedSample_HQ_transcript/56887 | Coverage 0.981 too low. | e29345d59042052e39eb0f1074ae0102 | 296 | Pfam | PF07716 | Basic region leucine zipper | 229 | 282 | 2.8E-16 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/57257|m.15494 | UnnamedSample_HQ_transcript/57257 | Identity 0.927 too low. | c74d1940fca3b36b8470fb1d164b734a | 460 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 147 | 228 | 8.1E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/54641|m.14976 | UnnamedSample_HQ_transcript/54641 | Coverage 0.860 too low. | 23e39d94f44df9cdb510869dfeea4c1b | 276 | Pfam | PF00169 | PH domain | 155 | 260 | 1.4E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/110071|m.23844 | UnnamedSample_HQ_transcript/110071 | Coverage 0.989 too low. | 30b5533735876adc05086de162c0b4b8 | 228 | Pfam | PF00651 | BTB/POZ domain | 48 | 153 | 6.4E-21 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18799|m.6529 | UnnamedSample_HQ_transcript/18799 | Coverage 0.917 too low. | f6c5bd6a435c085831bbfac261d30d26 | 1085 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 7.3E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/18799|m.6529 | UnnamedSample_HQ_transcript/18799 | Coverage 0.917 too low. | f6c5bd6a435c085831bbfac261d30d26 | 1085 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 5.2E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/18799|m.6529 | UnnamedSample_HQ_transcript/18799 | Coverage 0.917 too low. | f6c5bd6a435c085831bbfac261d30d26 | 1085 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 1081 | 3.8E-113 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/18799|m.6529 | UnnamedSample_HQ_transcript/18799 | Coverage 0.917 too low. | f6c5bd6a435c085831bbfac261d30d26 | 1085 | Pfam | PF01751 | Toprim domain | 457 | 558 | 5.7E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/18799|m.6529 | UnnamedSample_HQ_transcript/18799 | Coverage 0.917 too low. | f6c5bd6a435c085831bbfac261d30d26 | 1085 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.1E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/20184|m.6918 | UnnamedSample_HQ_transcript/20184 | Coverage 0.969 too low. | 41448e3f787dd94909ccaf93d91c82cb | 1041 | Pfam | PF00122 | E1-E2 ATPase | 182 | 372 | 5.6E-43 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20184|m.6918 | UnnamedSample_HQ_transcript/20184 | Coverage 0.969 too low. | 41448e3f787dd94909ccaf93d91c82cb | 1041 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 817 | 1025 | 4.3E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/20184|m.6918 | UnnamedSample_HQ_transcript/20184 | Coverage 0.969 too low. | 41448e3f787dd94909ccaf93d91c82cb | 1041 | Pfam | PF13246 | Cation transport ATPase (P-type) | 444 | 539 | 1.3E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20184|m.6918 | UnnamedSample_HQ_transcript/20184 | Coverage 0.969 too low. | 41448e3f787dd94909ccaf93d91c82cb | 1041 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 61 | 129 | 8.2E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/6023|m.2547 | UnnamedSample_HQ_transcript/6023 | Coverage 0.865 too low. | ec56d38f7c1666f0aa72f24e2b529d05 | 908 | Pfam | PF03131 | bZIP Maf transcription factor | 756 | 844 | 1.6E-21 | T | 22-09-2020 | IPR004826 | Basic leucine zipper domain, Maf-type |
| UnnamedSample_HQ_transcript/4712|m.2077 | UnnamedSample_HQ_transcript/4712 | Coverage 0.824 too low. | ec56d38f7c1666f0aa72f24e2b529d05 | 908 | Pfam | PF03131 | bZIP Maf transcription factor | 756 | 844 | 1.6E-21 | T | 22-09-2020 | IPR004826 | Basic leucine zipper domain, Maf-type |
| UnnamedSample_HQ_transcript/14422|m.5244 | UnnamedSample_HQ_transcript/14422 | Coverage 0.763 too low. | ec56d38f7c1666f0aa72f24e2b529d05 | 908 | Pfam | PF03131 | bZIP Maf transcription factor | 756 | 844 | 1.6E-21 | T | 22-09-2020 | IPR004826 | Basic leucine zipper domain, Maf-type |
| UnnamedSample_HQ_transcript/80525|m.19805 | UnnamedSample_HQ_transcript/80525 | Coverage 0.962 too low. | b94a532183a4a8a88317697ed4abd8c4 | 184 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 182 | 8.7E-39 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/60159|m.16091 | UnnamedSample_HQ_transcript/60159 | Coverage 0.902 too low. | ceb162b539d3f19fdaade5aa05869893 | 342 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.4E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60159|m.16091 | UnnamedSample_HQ_transcript/60159 | Coverage 0.902 too low. | ceb162b539d3f19fdaade5aa05869893 | 342 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 2.8E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/72071|m.18315 | UnnamedSample_HQ_transcript/72071 | Coverage 0.556 too low. | 7597f6cd19c91741d0a63a9a7ed0984c | 335 | Pfam | PF02913 | FAD linked oxidases, C-terminal domain | 88 | 331 | 1.1E-53 | T | 22-09-2020 | IPR004113 | FAD-linked oxidase, C-terminal |
| UnnamedSample_HQ_transcript/72071|m.18315 | UnnamedSample_HQ_transcript/72071 | Coverage 0.556 too low. | 7597f6cd19c91741d0a63a9a7ed0984c | 335 | Pfam | PF01565 | FAD binding domain | 2 | 51 | 1.5E-8 | T | 22-09-2020 | IPR006094 | FAD linked oxidase, N-terminal |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.018 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF12661 | Human growth factor-like EGF | 199 | 218 | 0.074 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0044 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.061 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/24673|m.8125 | UnnamedSample_HQ_transcript/24673 | Coverage 0.787 too low. | 8e4594912ba49015ee07cdad6a8b23ef | 885 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 7.6E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/59040|m.15859 | UnnamedSample_HQ_transcript/59040 | Coverage 0.144 too low. | 3dd70c1248c1b16727fc8b507ef11808 | 372 | Pfam | PF00999 | Sodium/hydrogen exchanger family | 85 | 287 | 8.7E-20 | T | 22-09-2020 | IPR006153 | Cation/H+ exchanger |
| UnnamedSample_HQ_transcript/93856|m.21790 | UnnamedSample_HQ_transcript/93856 | Coverage 0.973 too low. | 93a2ec4649ab15e24819144087787f37 | 374 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 64 | 317 | 8.7E-51 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/35156|m.10744 | UnnamedSample_HQ_transcript/35156 | Identity 0.734 too low. | 6308d247a69ecc5bc3906d5e25d22c79 | 554 | Pfam | PF00384 | Molybdopterin oxidoreductase | 129 | 455 | 1.2E-68 | T | 22-09-2020 | IPR006656 | Molybdopterin oxidoreductase |
| UnnamedSample_HQ_transcript/35156|m.10744 | UnnamedSample_HQ_transcript/35156 | Identity 0.734 too low. | 6308d247a69ecc5bc3906d5e25d22c79 | 554 | Pfam | PF09326 | NADH-ubiquinone oxidoreductase subunit G, C-terminal | 486 | 537 | 7.0E-13 | T | 22-09-2020 | IPR015405 | NADH-quinone oxidoreductase, chain G, C-terminal |
| UnnamedSample_HQ_transcript/50193|m.14058 | UnnamedSample_HQ_transcript/50193 | Identity 0.638 too low. | 5a619e0f2c9693e9723eb2ab5c410425 | 569 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 119 | 408 | 4.2E-116 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/47744|m.13520 | UnnamedSample_HQ_transcript/47744 | Coverage 0.627 too low. | 5a619e0f2c9693e9723eb2ab5c410425 | 569 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 119 | 408 | 4.2E-116 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/51984|m.14453 | UnnamedSample_HQ_transcript/51984 | Coverage 0.619 too low. | 5a619e0f2c9693e9723eb2ab5c410425 | 569 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 119 | 408 | 4.2E-116 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/54209|m.14878 | UnnamedSample_HQ_transcript/54209 | Identity 0.632 too low. | 5a619e0f2c9693e9723eb2ab5c410425 | 569 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 119 | 408 | 4.2E-116 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/31870|m.9916 | UnnamedSample_HQ_transcript/31870 | Coverage 0.466 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/30673|m.9638 | UnnamedSample_HQ_transcript/30673 | Coverage 0.424 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/44744|m.12862 | UnnamedSample_HQ_transcript/44744 | Coverage 0.543 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/51351|m.14316 | UnnamedSample_HQ_transcript/51351 | Coverage 0.505 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/22461|m.7556 | UnnamedSample_HQ_transcript/22461 | Coverage 0.489 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/34819|m.10679 | UnnamedSample_HQ_transcript/34819 | Coverage 0.449 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/35356|m.10789 | UnnamedSample_HQ_transcript/35356 | Coverage 0.475 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/14218|m.5178 | UnnamedSample_HQ_transcript/14218 | Coverage 0.429 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/24697|m.8131 | UnnamedSample_HQ_transcript/24697 | Coverage 0.516 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/27431|m.8817 | UnnamedSample_HQ_transcript/27431 | Coverage 0.445 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/42257|m.12323 | UnnamedSample_HQ_transcript/42257 | Coverage 0.532 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/53741|m.14791 | UnnamedSample_HQ_transcript/53741 | Coverage 0.559 too low. | 0c7fb9244f14b3d0c5aa8874eeb68a71 | 467 | Pfam | PF13632 | Glycosyl transferase family group 2 | 192 | 392 | 5.5E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/10244|m.3901 | UnnamedSample_HQ_transcript/10244 | Coverage 0.732 too low. | 56a55a848b0c81ccbd409034192fda44 | 599 | Pfam | PF16422 | Transcription factor COE1 DNA-binding domain | 57 | 260 | 3.2E-131 | T | 22-09-2020 | IPR032200 | Transcription factor COE, DNA-binding domain |
| UnnamedSample_HQ_transcript/10244|m.3901 | UnnamedSample_HQ_transcript/10244 | Coverage 0.732 too low. | 56a55a848b0c81ccbd409034192fda44 | 599 | Pfam | PF16423 | Transcription factor COE1 helix-loop-helix domain | 361 | 404 | 1.9E-29 | T | 22-09-2020 | IPR032201 | Transcription factor COE, helix-loop-helix domain |
| UnnamedSample_HQ_transcript/10244|m.3901 | UnnamedSample_HQ_transcript/10244 | Coverage 0.732 too low. | 56a55a848b0c81ccbd409034192fda44 | 599 | Pfam | PF01833 | IPT/TIG domain | 276 | 358 | 6.7E-12 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/47887|m.13555 | UnnamedSample_HQ_transcript/47887 | Coverage 0.948 too low. | 2dea35124379bec4b764c119f56efcfa | 316 | Pfam | PF00012 | Hsp70 protein | 6 | 314 | 2.1E-149 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/22463|m.7557 | UnnamedSample_HQ_transcript/22463 | Coverage 0.907 too low. | 546e5e6a8f7f0f6696d27c913870bed1 | 650 | Pfam | PF00651 | BTB/POZ domain | 26 | 123 | 5.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/22463|m.7557 | UnnamedSample_HQ_transcript/22463 | Coverage 0.907 too low. | 546e5e6a8f7f0f6696d27c913870bed1 | 650 | Pfam | PF05225 | helix-turn-helix, Psq domain | 409 | 449 | 4.1E-8 | T | 22-09-2020 | IPR007889 | DNA binding HTH domain, Psq-type |
| UnnamedSample_HQ_transcript/24004|m.7948 | UnnamedSample_HQ_transcript/24004 | Coverage 0.980 too low. | aa81018e0363c457d90282b9587e33a5 | 920 | Pfam | PF08366 | LLGL2 | 144 | 237 | 4.2E-30 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/22661|m.7607 | UnnamedSample_HQ_transcript/22661 | Coverage 0.896 too low. | 07ce70ee817bad350718975268b2e45a | 927 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 99 | 358 | 9.8E-67 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/22661|m.7607 | UnnamedSample_HQ_transcript/22661 | Coverage 0.896 too low. | 07ce70ee817bad350718975268b2e45a | 927 | Pfam | PF00018 | SH3 domain | 32 | 81 | 4.1E-12 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/108035|m.23581 | UnnamedSample_HQ_transcript/108035 | Coverage 0.948 too low. | 1eb5c0436df5994b4b4c234b0f5705bd | 190 | Pfam | PF01380 | SIS domain | 43 | 172 | 7.9E-27 | T | 22-09-2020 | IPR001347 | Sugar isomerase (SIS) |
| UnnamedSample_HQ_transcript/46248|m.13194 | UnnamedSample_HQ_transcript/46248 | Coverage 0.764 too low. | 81c4784e931c66419f57a8b5aa3dfc42 | 485 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 260 | 334 | 2.0E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/46248|m.13194 | UnnamedSample_HQ_transcript/46248 | Coverage 0.764 too low. | 81c4784e931c66419f57a8b5aa3dfc42 | 485 | Pfam | PF00620 | RhoGAP domain | 50 | 200 | 7.8E-40 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/35447|m.10806 | UnnamedSample_HQ_transcript/35447 | Coverage 0.630 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 313 | 349 | 9.2E-7 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/35447|m.10806 | UnnamedSample_HQ_transcript/35447 | Coverage 0.630 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 232 | 297 | 3.9E-13 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/69178|m.17789 | UnnamedSample_HQ_transcript/69178 | Coverage 0.453 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 313 | 349 | 9.2E-7 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/69178|m.17789 | UnnamedSample_HQ_transcript/69178 | Coverage 0.453 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 232 | 297 | 3.9E-13 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/48062|m.13593 | UnnamedSample_HQ_transcript/48062 | Coverage 0.570 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 313 | 349 | 9.2E-7 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/48062|m.13593 | UnnamedSample_HQ_transcript/48062 | Coverage 0.570 too low. | 743786d01a2446992cd2f76183e3bcfd | 453 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 232 | 297 | 3.9E-13 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/51861|m.14419 | UnnamedSample_HQ_transcript/51861 | Identity 0.865 too low. | b891a204da6b86d806e56c2de6398b3f | 247 | Pfam | PF03166 | MH2 domain | 19 | 226 | 2.7E-71 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/28990|m.9224 | UnnamedSample_HQ_transcript/28990 | Coverage 0.985 too low. | 0790b117290b321dbe0d3cd814852058 | 665 | Pfam | PF09820 | Predicted AAA-ATPase | 37 | 362 | 4.6E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/30657|m.9635 | UnnamedSample_HQ_transcript/30657 | Coverage 0.976 too low. | 0790b117290b321dbe0d3cd814852058 | 665 | Pfam | PF09820 | Predicted AAA-ATPase | 37 | 362 | 4.6E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/28220|m.9019 | UnnamedSample_HQ_transcript/28220 | Coverage 0.977 too low. | 0790b117290b321dbe0d3cd814852058 | 665 | Pfam | PF09820 | Predicted AAA-ATPase | 37 | 362 | 4.6E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/35498|m.10815 | UnnamedSample_HQ_transcript/35498 | Coverage 0.973 too low. | 0790b117290b321dbe0d3cd814852058 | 665 | Pfam | PF09820 | Predicted AAA-ATPase | 37 | 362 | 4.6E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/29419|m.9331 | UnnamedSample_HQ_transcript/29419 | Coverage 0.989 too low. | 0790b117290b321dbe0d3cd814852058 | 665 | Pfam | PF09820 | Predicted AAA-ATPase | 37 | 362 | 4.6E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/30777|m.9655 | UnnamedSample_HQ_transcript/30777 | Coverage 0.966 too low. | b0b10ae722e770c3ee30606b8dcfe058 | 532 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 14 | 119 | 3.4E-32 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/5051|m.2213 | UnnamedSample_HQ_transcript/5051 | Coverage 0.075 too low. | 469ce9487a9a3038d61996d30a836cd2 | 1467 | Pfam | PF00595 | PDZ domain | 755 | 837 | 1.3E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/5051|m.2213 | UnnamedSample_HQ_transcript/5051 | Coverage 0.075 too low. | 469ce9487a9a3038d61996d30a836cd2 | 1467 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 1392 | 1450 | 5.7E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/5051|m.2213 | UnnamedSample_HQ_transcript/5051 | Coverage 0.075 too low. | 469ce9487a9a3038d61996d30a836cd2 | 1467 | Pfam | PF17817 | PDZ domain | 674 | 746 | 2.3E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/64205|m.16888 | UnnamedSample_HQ_transcript/64205 | Unmapped. | e84d869f6f37ed5e378067981b045d77 | 476 | Pfam | PF06460 | Coronavirus 2'-O-methyltransferase | 272 | 432 | 8.3E-5 | T | 22-09-2020 | IPR009461 | Non-structural protein NSP16, coronavirus-like |
| UnnamedSample_HQ_transcript/95464|m.22021 | UnnamedSample_HQ_transcript/95464 | Coverage 0.988 too low. | 218a097ae10a7720072e4fc13b596917 | 386 | Pfam | PF00439 | Bromodomain | 117 | 196 | 1.5E-22 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/44177|m.12754 | UnnamedSample_HQ_transcript/44177 | Coverage 0.075 too low. | ab78e981672a69cbad1ce2379bfcdeea | 707 | Pfam | PF09261 | Alpha mannosidase middle domain | 108 | 212 | 3.0E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/44177|m.12754 | UnnamedSample_HQ_transcript/44177 | Coverage 0.075 too low. | ab78e981672a69cbad1ce2379bfcdeea | 707 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 4 | 102 | 4.4E-18 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/44177|m.12754 | UnnamedSample_HQ_transcript/44177 | Coverage 0.075 too low. | ab78e981672a69cbad1ce2379bfcdeea | 707 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 374 | 576 | 8.6E-30 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/62594|m.16553 | UnnamedSample_HQ_transcript/62594 | Coverage 0.193 too low. | a6595603a290c67ae1e16b8f883a468b | 509 | Pfam | PF13424 | Tetratricopeptide repeat | 299 | 373 | 4.9E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62594|m.16553 | UnnamedSample_HQ_transcript/62594 | Coverage 0.193 too low. | a6595603a290c67ae1e16b8f883a468b | 509 | Pfam | PF13424 | Tetratricopeptide repeat | 216 | 290 | 1.9E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62594|m.16553 | UnnamedSample_HQ_transcript/62594 | Coverage 0.193 too low. | a6595603a290c67ae1e16b8f883a468b | 509 | Pfam | PF13374 | Tetratricopeptide repeat | 468 | 498 | 3.7E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62594|m.16553 | UnnamedSample_HQ_transcript/62594 | Coverage 0.193 too low. | a6595603a290c67ae1e16b8f883a468b | 509 | Pfam | PF13176 | Tetratricopeptide repeat | 388 | 415 | 2.4E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/63536|m.16737 | UnnamedSample_HQ_transcript/63536 | Identity 0.930 too low. | 6a67d313cd3d21c3c6b86ea7d4c51d59 | 467 | Pfam | PF00083 | Sugar (and other) transporter | 53 | 449 | 1.2E-57 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/34105|m.10494 | UnnamedSample_HQ_transcript/34105 | Coverage 0.544 too low. | 3a6fb2f8fb87bc7965806e5953b2de9f | 351 | Pfam | PF00250 | Forkhead domain | 88 | 170 | 4.4E-27 | T | 22-09-2020 | IPR001766 | Fork head domain |
| UnnamedSample_HQ_transcript/83131|m.20214 | UnnamedSample_HQ_transcript/83131 | Coverage 0.808 too low. | e705a94de17ee399b06ab71cd0824d42 | 440 | Pfam | PF05470 | Eukaryotic translation initiation factor 3 subunit 8 N-terminus | 2 | 355 | 1.5E-72 | T | 22-09-2020 | IPR008905 | Eukaryotic translation initiation factor 3 subunit C, N-terminal domain |
| UnnamedSample_HQ_transcript/105888|m.23324 | UnnamedSample_HQ_transcript/105888 | Coverage 0.989 too low. | aa6fbf242c2fce5a71284f240e1e6b25 | 330 | Pfam | PF01028 | Eukaryotic DNA topoisomerase I, catalytic core | 63 | 293 | 3.2E-98 | T | 22-09-2020 | IPR013500 | DNA topoisomerase I, catalytic core, eukaryotic-type |
| UnnamedSample_HQ_transcript/105888|m.23324 | UnnamedSample_HQ_transcript/105888 | Coverage 0.989 too low. | aa6fbf242c2fce5a71284f240e1e6b25 | 330 | Pfam | PF02919 | Eukaryotic DNA topoisomerase I, DNA binding fragment | 1 | 60 | 6.6E-26 | T | 22-09-2020 | IPR008336 | DNA topoisomerase I, DNA binding, eukaryotic-type |
| UnnamedSample_HQ_transcript/109336|m.23757 | UnnamedSample_HQ_transcript/109336 | Coverage 0.659 too low. | ef472efaf25e28e0b8cba1cb88ec8d7b | 148 | Pfam | PF00203 | Ribosomal protein S19 | 46 | 131 | 5.0E-35 | T | 22-09-2020 | IPR002222 | Ribosomal protein S19/S15 |
| UnnamedSample_HQ_transcript/113951|m.24292 | UnnamedSample_HQ_transcript/113951 | Coverage 0.741 too low. | ef472efaf25e28e0b8cba1cb88ec8d7b | 148 | Pfam | PF00203 | Ribosomal protein S19 | 46 | 131 | 5.0E-35 | T | 22-09-2020 | IPR002222 | Ribosomal protein S19/S15 |
| UnnamedSample_HQ_transcript/118241|m.24698 | UnnamedSample_HQ_transcript/118241 | Coverage 0.844 too low. | ef472efaf25e28e0b8cba1cb88ec8d7b | 148 | Pfam | PF00203 | Ribosomal protein S19 | 46 | 131 | 5.0E-35 | T | 22-09-2020 | IPR002222 | Ribosomal protein S19/S15 |
| UnnamedSample_HQ_transcript/32498|m.10082 | UnnamedSample_HQ_transcript/32498 | Unmapped. | 4bfb244a24979599773fb0d5712aaaa8 | 909 | Pfam | PF08762 | CRPV capsid protein like | 595 | 805 | 1.3E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/95021|m.21962 | UnnamedSample_HQ_transcript/95021 | Coverage 0.422 too low. | f79904760e4d7014c17f79d229238cb1 | 156 | Pfam | PF00274 | Fructose-bisphosphate aldolase class-I | 1 | 156 | 2.8E-82 | T | 22-09-2020 | IPR000741 | Fructose-bisphosphate aldolase, class-I |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1211 | 1320 | 8.7E-42 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1101 | 1206 | 2.5E-38 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 707 | 762 | 2.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 936 | 990 | 1.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 543 | 601 | 1.4E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 129 | 183 | 6.9E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 644 | 700 | 5.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 198 | 252 | 1.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 945 | 1002 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 500 | 556 | 9.8E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 771 | 822 | 6.5E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1035 | 1092 | 1.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5219|m.2268 | UnnamedSample_HQ_transcript/5219 | Identity 0.923 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 403 | 456 | 1.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1211 | 1320 | 8.7E-42 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1101 | 1206 | 2.5E-38 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 707 | 762 | 2.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 936 | 990 | 1.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 543 | 601 | 1.4E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 129 | 183 | 6.9E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 644 | 700 | 5.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 198 | 252 | 1.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 945 | 1002 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 500 | 556 | 9.8E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 771 | 822 | 6.5E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 1035 | 1092 | 1.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6774|m.2794 | UnnamedSample_HQ_transcript/6774 | Identity 0.919 too low. | c254d9c3a7bb3601e041a4f99718a99e | 1343 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 403 | 456 | 1.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 1 | 86 | 3.9E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 1062 | 1174 | 1.3E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 2013 | 2121 | 3.0E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 715 | 821 | 8.5E-19 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 891 | 994 | 1.5E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 354 | 461 | 1.3E-10 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 169 | 286 | 3.8E-17 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/509|m.376 | UnnamedSample_HQ_transcript/509 | Coverage 0.570 too low. | 275a14c5e107231750003c3c97e852d6 | 2198 | Pfam | PF00567 | Tudor domain | 545 | 612 | 1.9E-6 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/29439|m.9339 | UnnamedSample_HQ_transcript/29439 | Coverage 0.985 too low. | d374a4e67de6dbe1d5ce102f05e31820 | 898 | Pfam | PF00458 | WHEP-TRS domain | 865 | 897 | 5.7E-8 | T | 22-09-2020 | IPR000738 | WHEP-TRS domain |
| UnnamedSample_HQ_transcript/29439|m.9339 | UnnamedSample_HQ_transcript/29439 | Coverage 0.985 too low. | d374a4e67de6dbe1d5ce102f05e31820 | 898 | Pfam | PF09334 | tRNA synthetases class I (M) | 279 | 670 | 9.1E-149 | T | 22-09-2020 | IPR015413 | Methionyl/Leucyl tRNA synthetase |
| UnnamedSample_HQ_transcript/29439|m.9339 | UnnamedSample_HQ_transcript/29439 | Coverage 0.985 too low. | d374a4e67de6dbe1d5ce102f05e31820 | 898 | Pfam | PF18485 | Glutathione S-transferase, N-terminal domain | 28 | 94 | 1.8E-11 | T | 22-09-2020 | IPR041598 | Methionine--tRNA ligase, N-terminal |
| UnnamedSample_HQ_transcript/110908|m.23953 | UnnamedSample_HQ_transcript/110908 | Coverage 0.980 too low. | 12460f3798df03b282a742d5fdb61617 | 185 | Pfam | PF00089 | Trypsin | 1 | 181 | 8.5E-37 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/1213|m.729 | UnnamedSample_HQ_transcript/1213 | Unmapped. | a320b8d03906b115ab11140b65f03162 | 1975 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1609 | 1934 | 7.4E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/1213|m.729 | UnnamedSample_HQ_transcript/1213 | Unmapped. | a320b8d03906b115ab11140b65f03162 | 1975 | Pfam | PF00910 | RNA helicase | 547 | 655 | 7.5E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/68318|m.17641 | UnnamedSample_HQ_transcript/68318 | Coverage 0.861 too low. | 2e44f6749e0145285a99e7a2ffa3af15 | 197 | Pfam | PF00012 | Hsp70 protein | 12 | 196 | 9.5E-92 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/61574|m.16365 | UnnamedSample_HQ_transcript/61574 | Coverage 0.476 too low. | 0d00ea9b6379847301bd42dfabb542eb | 503 | Pfam | PF00176 | SNF2 family N-terminal domain | 3 | 199 | 5.5E-37 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/61574|m.16365 | UnnamedSample_HQ_transcript/61574 | Coverage 0.476 too low. | 0d00ea9b6379847301bd42dfabb542eb | 503 | Pfam | PF00271 | Helicase conserved C-terminal domain | 243 | 349 | 1.1E-16 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/59174|m.15883 | UnnamedSample_HQ_transcript/59174 | Identity 0.651 too low. | 12f507cc84d345b1879c030972819cac | 371 | Pfam | PF09457 | FIP domain | 327 | 367 | 9.3E-12 | T | 22-09-2020 | IPR019018 | Rab-binding domain FIP-RBD |
| UnnamedSample_HQ_transcript/2342|m.1187 | UnnamedSample_HQ_transcript/2342 | Coverage 0.119 too low. | 76969e6b1c46e70cfed3f35031c1c605 | 1030 | Pfam | PF08447 | PAS fold | 238 | 323 | 1.0E-14 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/2342|m.1187 | UnnamedSample_HQ_transcript/2342 | Coverage 0.119 too low. | 76969e6b1c46e70cfed3f35031c1c605 | 1030 | Pfam | PF00989 | PAS fold | 71 | 130 | 1.1E-9 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/60012|m.16061 | UnnamedSample_HQ_transcript/60012 | Coverage 0.929 too low. | 29f26acc4f7d2380abc64e09583a6813 | 430 | Pfam | PF01007 | Inward rectifier potassium channel transmembrane domain | 34 | 182 | 1.1E-60 | T | 22-09-2020 | IPR040445 | Potassium channel, inwardly rectifying, transmembrane domain |
| UnnamedSample_HQ_transcript/60012|m.16061 | UnnamedSample_HQ_transcript/60012 | Coverage 0.929 too low. | 29f26acc4f7d2380abc64e09583a6813 | 430 | Pfam | PF17655 | Inward rectifier potassium channel C-terminal domain | 189 | 359 | 9.5E-76 | T | 22-09-2020 | IPR041647 | Inward rectifier potassium channel, C-terminal |
| UnnamedSample_HQ_transcript/66901|m.17388 | UnnamedSample_HQ_transcript/66901 | Coverage 0.912 too low. | 29f26acc4f7d2380abc64e09583a6813 | 430 | Pfam | PF01007 | Inward rectifier potassium channel transmembrane domain | 34 | 182 | 1.1E-60 | T | 22-09-2020 | IPR040445 | Potassium channel, inwardly rectifying, transmembrane domain |
| UnnamedSample_HQ_transcript/66901|m.17388 | UnnamedSample_HQ_transcript/66901 | Coverage 0.912 too low. | 29f26acc4f7d2380abc64e09583a6813 | 430 | Pfam | PF17655 | Inward rectifier potassium channel C-terminal domain | 189 | 359 | 9.5E-76 | T | 22-09-2020 | IPR041647 | Inward rectifier potassium channel, C-terminal |
| UnnamedSample_HQ_transcript/12270|m.4582 | UnnamedSample_HQ_transcript/12270 | Identity 0.761 too low. | eac9a16fb8f3cbd470338d7f3daf8f80 | 1005 | Pfam | PF01753 | MYND finger | 966 | 1003 | 4.7E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/28237|m.9027 | UnnamedSample_HQ_transcript/28237 | Coverage 0.231 too low. | 8ed4448e26df3904278808a4796ad4bf | 896 | Pfam | PF08447 | PAS fold | 247 | 332 | 8.4E-15 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/28237|m.9027 | UnnamedSample_HQ_transcript/28237 | Coverage 0.231 too low. | 8ed4448e26df3904278808a4796ad4bf | 896 | Pfam | PF00989 | PAS fold | 80 | 139 | 9.5E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/109989|m.23827 | UnnamedSample_HQ_transcript/109989 | Coverage 0.668 too low. | 627c868f31b34315fbc9d3b2117b2879 | 140 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 8.2E-23 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/8727|m.3426 | UnnamedSample_HQ_transcript/8727 | Identity 0.854 too low. | 9792311a6bb2eb5482b26d9cad519912 | 929 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 606 | 863 | 1.4E-114 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF00023 | Ankyrin repeat | 950 | 981 | 0.0077 | T | 22-09-2020 | IPR002110 | Ankyrin repeat |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 710 | 778 | 2.8E-14 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 1187 | 1241 | 7.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 1090 | 1184 | 3.2E-18 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 997 | 1081 | 2.4E-9 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/5653|m.2410 | UnnamedSample_HQ_transcript/5653 | Identity 0.940 too low. | 7d70e42e6e07e25ff0bb9ed4a939223b | 1241 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 853 | 946 | 1.0E-20 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/91464|m.21468 | UnnamedSample_HQ_transcript/91464 | Coverage 0.231 too low. | 34c21af2bd1229b14235c2f571ce7712 | 334 | Pfam | PF00096 | Zinc finger, C2H2 type | 306 | 329 | 0.0086 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/15002|m.5399 | UnnamedSample_HQ_transcript/15002 | Coverage 0.288 too low. | 132fddad3b4e91040075445cd67a2cdb | 451 | Pfam | PF00664 | ABC transporter transmembrane region | 1 | 164 | 2.7E-13 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/15002|m.5399 | UnnamedSample_HQ_transcript/15002 | Coverage 0.288 too low. | 132fddad3b4e91040075445cd67a2cdb | 451 | Pfam | PF00005 | ABC transporter | 232 | 366 | 2.6E-21 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/2311|m.1175 | UnnamedSample_HQ_transcript/2311 | Coverage 0.362 too low. | 87f1698bc9206ac1a9fff88d8d72f0ee | 792 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 377 | 774 | 1.2E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/2069|m.1086 | UnnamedSample_HQ_transcript/2069 | Coverage 0.354 too low. | 87f1698bc9206ac1a9fff88d8d72f0ee | 792 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 377 | 774 | 1.2E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/3757|m.1718 | UnnamedSample_HQ_transcript/3757 | Coverage 0.083 too low. | 87f1698bc9206ac1a9fff88d8d72f0ee | 792 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 377 | 774 | 1.2E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/62651|m.16568 | UnnamedSample_HQ_transcript/62651 | Coverage 0.722 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/62651|m.16568 | UnnamedSample_HQ_transcript/62651 | Coverage 0.722 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/62651|m.16568 | UnnamedSample_HQ_transcript/62651 | Coverage 0.722 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/76847|m.19180 | UnnamedSample_HQ_transcript/76847 | Coverage 0.685 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/76847|m.19180 | UnnamedSample_HQ_transcript/76847 | Coverage 0.685 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/76847|m.19180 | UnnamedSample_HQ_transcript/76847 | Coverage 0.685 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/61935|m.16437 | UnnamedSample_HQ_transcript/61935 | Coverage 0.745 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/61935|m.16437 | UnnamedSample_HQ_transcript/61935 | Coverage 0.745 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/61935|m.16437 | UnnamedSample_HQ_transcript/61935 | Coverage 0.745 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/61416|m.16342 | UnnamedSample_HQ_transcript/61416 | Coverage 0.740 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/61416|m.16342 | UnnamedSample_HQ_transcript/61416 | Coverage 0.740 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/61416|m.16342 | UnnamedSample_HQ_transcript/61416 | Coverage 0.740 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/66954|m.17402 | UnnamedSample_HQ_transcript/66954 | Coverage 0.762 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/66954|m.17402 | UnnamedSample_HQ_transcript/66954 | Coverage 0.762 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/66954|m.17402 | UnnamedSample_HQ_transcript/66954 | Coverage 0.762 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/70190|m.17955 | UnnamedSample_HQ_transcript/70190 | Coverage 0.818 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/70190|m.17955 | UnnamedSample_HQ_transcript/70190 | Coverage 0.818 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/70190|m.17955 | UnnamedSample_HQ_transcript/70190 | Coverage 0.818 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/73125|m.18497 | UnnamedSample_HQ_transcript/73125 | Coverage 0.805 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF17862 | AAA+ lid domain | 369 | 411 | 4.3E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/73125|m.18497 | UnnamedSample_HQ_transcript/73125 | Coverage 0.805 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 213 | 345 | 2.8E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/73125|m.18497 | UnnamedSample_HQ_transcript/73125 | Coverage 0.805 too low. | 0c11cb951c345aded41d60a8578bea8c | 433 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 100 | 155 | 1.6E-6 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 916 | 970 | 8.0E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 98 | 2.3E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 310 | 365 | 1.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 628 | 685 | 4.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 376 | 426 | 2.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/27683|m.8883 | UnnamedSample_HQ_transcript/27683 | Coverage 0.035 too low. | ec9f780f62f054573199e23a94670ebb | 970 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 175 | 225 | 7.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
